| Completed |
: Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2007-12-06
: - Biological: filgrastim
- Biological: pegfilg
|
| Active, not recruiting |
: Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2007-11-21
: - Biological: filgrastim Stem ce
|
| Completed |
: Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Can
: 2007-10-22
: - Biological: filgrastim
- Drug: cisplatin
|
| Completed |
: Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
: - Platinum Refractory Epithelial Ovarian Cancer
- Primary Cancer of the Peritoneum
: 2007-10-10
: - Drug: Sunitinib Sunitinib, ora
|
| Terminated |
: Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
: - Constipation
- Bowel Obstruction
- Fallopian Tube Cancer
: 2007-09-27
|
| Terminated |
: Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2007-08-28
: - Drug: sorafenib tosylate
- Other: immunoenzy
|
| Completed |
: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors
: - Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Ca
: 2007-08-22
: - Drug: bevacizumab Other Names:
|
| Completed |
: Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire
: - Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Neoplasms<
: 2007-08-16
: - Drug: Paclitaxel
- Drug: EPO
|
| Terminated |
: A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
: - Ovarian Cancer
- Peritoneal Neoplasms
: 2007-08-14
: Drug: Volociximab 15 mg/kg weekly, IV infusions, for 8 weeks or until disease progression or unacceptabl
|
| Completed |
: Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
: - Fallopian Tube Cancer
- Ovarian Cancer
- Malignant Tumor of Pe
: 2007-07-17
: - Drug: Avastin Day 1, every 21
|
